Glenmede Trust Co. NA Sells 6,500 Shares of Colgate-Palmolive (NYSE:CL)

Glenmede Trust Co. NA lessened its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 1.1% in the third quarter, Holdings Channel.com reports. The firm owned 565,831 shares of the company’s stock after selling 6,500 shares during the period. Glenmede Trust Co. NA’s holdings in Colgate-Palmolive were worth $58,739,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently modified their holdings of the business. E Fund Management Hong Kong Co. Ltd. purchased a new position in shares of Colgate-Palmolive in the second quarter valued at $25,000. Continuum Advisory LLC lifted its holdings in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after buying an additional 125 shares in the last quarter. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive during the third quarter valued at approximately $42,000. Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $53,000. Finally, Prospera Private Wealth LLC bought a new position in Colgate-Palmolive in the 3rd quarter valued at $64,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.37% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on CL shares. UBS Group boosted their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research note on Monday, October 28th. JPMorgan Chase & Co. increased their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Sanford C. Bernstein raised their price objective on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research note on Tuesday, July 30th. Finally, Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price target for the company from $105.00 to $101.00 in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $105.11.

View Our Latest Stock Analysis on CL

Colgate-Palmolive Trading Up 1.3 %

Shares of CL stock opened at $96.59 on Wednesday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a fifty day moving average price of $97.74 and a 200-day moving average price of $98.59. The company has a market cap of $78.91 billion, a price-to-earnings ratio of 27.68, a PEG ratio of 3.40 and a beta of 0.42. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.